Your browser doesn't support javascript.
loading
[Practical use of digital health applications (DiGA) in internal medicine]. / Praktische Anwendung digitaler Gesundheitsanwendungen (DiGA) in der Inneren Medizin.
Mittermaier, Mirja; Sina, Christian; Richter, Jutta G; Raspe, Matthias; Stais, Patrick; Vehreschild, Jörg; Wolfrum, Sebastian; Anthes, Christina; Möckel, Martin.
Affiliation
  • Mittermaier M; Medizinische Klinik m.S. Infektiologie und Pneumologie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
  • Sina C; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
  • Richter JG; Institut für Ernährungsmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland.
  • Raspe M; Poliklinik und Funktionsbereich Rheumatologie & Hiller-Forschungszentrum Rheumatologie, Medizinische Fakultät, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
  • Stais P; Medizinische Klinik m.S. Infektiologie und Pneumologie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
  • Vehreschild J; Medizinische Klinik 3, Lungen- und Bronchialheilkunde, Lungen-Thorax-Zentrum Nordrhein, Moers, Deutschland.
  • Wolfrum S; Medizinische Klinik 2, Universitätsklinikum Frankfurt, Frankfurt, Deutschland.
  • Anthes C; AG Kohorten, Klinik I für Innere Medizin, Uniklinik Köln, Köln, Deutschland.
  • Möckel M; Deutsches Zentrum für Infektionsforschung, Köln, Deutschland.
Internist (Berl) ; 63(3): 245-254, 2022 Mar.
Article in De | MEDLINE | ID: mdl-35037948
ABSTRACT
Since 2020 physicians can prescribe digital health applications (DiGA), also colloquially known as apps on prescription, which are reimbursed by the statutory health insurance when they are approved by the Federal Institute for Drugs and Medical Devices (BfArM) and are included in the DiGA Ordinance. Currently, there is one approved DiGA (indication obesity) for internal medicine. There are many questions on the practical use of the DiGA, ranging from the prescription, the effectiveness, the complexities and reimbursement as well as the liability risks. The DiGA are innovative new means, which maybe support internal medicine physicians in the diagnostics and treatment in the future. The benefits in this field of indications are limited by unclarified issues, especially on the prescription practice and the currently low number of DiGA available in internal medicine.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Physicians / National Health Programs Limits: Humans Country/Region as subject: Europa Language: De Journal: Internist (Berl) Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Physicians / National Health Programs Limits: Humans Country/Region as subject: Europa Language: De Journal: Internist (Berl) Year: 2022 Type: Article